CIK 0001620463
- Non-accelerated filer
- Smaller reporting company
LeonaBio, Inc.
Sign in to watch- Ticker
- LONA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 453368487
- Phone
- +1 425-620-8501
- Business address
- 18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL, WA, 98011
- Former names
- Athira Pharma, Inc., M3 Biotechnology, Inc.
- Open-market buys, last 90 days
- $9,919,161,281
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,919,161,281. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-02 | Gengos Andrew | Purchase | +3,418 | $2.95 | $10K | 20,012 |
| 2023-06-02 | MOEBIUS HANS Chief Medical Officer | Exercise or conversion | +7,882 | $1.35 | $11K | 81,482 |
| 2023-06-02 | MOEBIUS HANS Chief Medical Officer | Exercise or conversion · Stock Option (Right to Buy) | −7,882 | 0 | ||
| 2023-05-19 | Romano Kelly A Director | Grant or award · Stock Option (Right to Buy) | +20,900 | 20,900 | ||
| 2023-05-19 | JOHNSON JAMES A Director | Grant or award · Stock Option (Right to Buy) | +20,900 | 20,900 | ||
| 2023-05-19 | Kosacz Barbara Director | Grant or award · Stock Option (Right to Buy) | +20,900 | 20,900 | ||
| 2023-05-19 | EDELMAN JOSEPH Director | Grant or award · Stock Option (Right to Buy) | +20,900 | 20,900 | ||
| 2023-05-19 | Panzara Michael A. Director | Grant or award · Stock Option (Right to Buy) | +20,900 | 20,900 | ||
| 2023-05-19 | FLUKE JOHN M JR Director | Grant or award · Stock Option (Right to Buy) | +20,900 | 20,900 | ||
| 2023-05-19 | PICKERING GRANT Director | Grant or award · Stock Option (Right to Buy) | +20,900 | 20,900 | ||
| 2023-05-18 | Worthington Mark GENERAL COUNSEL | Grant or award | +7,767 | $2.41 | $19K | 26,864 |
| 2023-05-18 | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | Grant or award | +809 | $2.41 | $2K | 69,271 |
| 2023-05-18 | Worthington Mark General Counsel | Grant or award | +7,767 | $2.41 | $19K | 26,864 |
| 2023-05-18 | CHURCH KEVIN Chief Scientific Officer | Grant or award | +809 | $2.41 | $2K | 69,271 |
| 2023-05-18 | MOEBIUS HANS Chief Medical Officer | Grant or award | +7,764 | $2.41 | $19K | 73,600 |
| 2023-05-18 | Gengos Andrew | Grant or award · Stock Options (right to buy) | +400,000 | 400,000 | ||
| 2023-03-30 | PICKERING GRANT Director | Purchase | +15,000 | $2.47 | $37K | 25,783 |
| 2023-03-29 | PICKERING GRANT Director | Purchase | +10,000 | $2.33 | $23K | 10,783 |
| 2023-03-29 | JOHNSON JAMES A Director | Purchase | +5,000 | $2.40 | $12K | 5,000 |
| 2023-03-24 | CHURCH KEVIN Chief Scientific Officer | Exercise or conversion | +6,410 | $1.35 | $9K | 68,462 |
Page 11 of 18 · 349 trades